rs200377377
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015161.3(ARL6IP1):āc.490A>Cā(p.Ile164Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000366 in 1,610,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.00019 ( 0 hom., cov: 33)
Exomes š: 0.000021 ( 0 hom. )
Consequence
ARL6IP1
NM_015161.3 missense
NM_015161.3 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 5.09
Genes affected
ARL6IP1 (HGNC:697): (ADP ribosylation factor like GTPase 6 interacting protein 1) This gene belongs to the ARL6ip family and encodes a transmembrane protein that is predominantly localized to intracytoplasmic membranes. It is highly expressed in early myeloid progenitor cells and thought to be involved in protein transport, membrane trafficking, or cell signaling during hematopoietic maturation. Mutations in this gene are associated with spastic paraplegia 61 (SPG61). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08177599).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL6IP1 | NM_015161.3 | c.490A>C | p.Ile164Leu | missense_variant | 5/6 | ENST00000304414.12 | NP_055976.1 | |
ARL6IP1 | NM_001313858.1 | c.403A>C | p.Ile135Leu | missense_variant | 5/6 | NP_001300787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL6IP1 | ENST00000304414.12 | c.490A>C | p.Ile164Leu | missense_variant | 5/6 | 1 | NM_015161.3 | ENSP00000306788 | P1 | |
ARL6IP1 | ENST00000563861.5 | c.*72A>C | 3_prime_UTR_variant, NMD_transcript_variant | 4/5 | 1 | ENSP00000456596 | ||||
ARL6IP1 | ENST00000546206.6 | c.403A>C | p.Ile135Leu | missense_variant | 5/6 | 2 | ENSP00000440048 | |||
ARL6IP1 | ENST00000562819.5 | c.149-1232A>C | intron_variant | 5 | ENSP00000457372 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152192Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
29
AN:
152192
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251200Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135772
GnomAD3 exomes
AF:
AC:
17
AN:
251200
Hom.:
AF XY:
AC XY:
8
AN XY:
135772
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1458536Hom.: 0 Cov.: 29 AF XY: 0.0000193 AC XY: 14AN XY: 725714
GnomAD4 exome
AF:
AC:
30
AN:
1458536
Hom.:
Cov.:
29
AF XY:
AC XY:
14
AN XY:
725714
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000190 AC: 29AN: 152310Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74480
GnomAD4 genome
AF:
AC:
29
AN:
152310
Hom.:
Cov.:
33
AF XY:
AC XY:
21
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 61 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 164 of the ARL6IP1 protein (p.Ile164Leu). This variant is present in population databases (rs200377377, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with ARL6IP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 474863). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2022 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;D;D
Sift4G
Benign
T;D;D
Polyphen
0.48
.;P;.
Vest4
0.44, 0.45
MutPred
Loss of catalytic residue at L169 (P = 0.093);Loss of catalytic residue at L169 (P = 0.093);.;
MVP
MPC
0.57
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at